BARDA-Supported Molecular Diagnostic Test for Six Biothreat Pathogens Receives U.S. Food and Drug Administration (FDA) Clearance

The T2Biothreat Panel from BARDA partner T2 Biosystems, Inc. becomes the latest BARDA-supported medical countermeasure to receive FDA clearance.

Read the full press release from BARDA.